Skip to main content
Watch Insiders

Corporate insider profile

John W Smither Insider Trades

Latest reported as Director of NewAmsterdam Pharma Co N.V. (NAMS).

Purchase filings
0
Reported companies
2
Net open-market value
-$75,410.40
Latest transaction
Sep 4, 2026

Affiliated corporations

Reported company relationships

NAMSLatest reported

NewAmsterdam Pharma Co N.V.

Director

GNLXPrior filing

GENELUX Corp

Corporate insider

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Sep 4, 2026NewAmsterdam Pharma Co N.V. (NAMS)DirectorSale1,600$25.32$40,512
Jul 1, 2026GENELUX Corp (GNLX)Corporate insiderSale12,000$2.91$34,898